loadpatents
name:-0.024276971817017
name:-0.012142896652222
name:-0.0048680305480957
Jang; Sung Key Patent Filings

Jang; Sung Key

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jang; Sung Key.The latest application filed is for "fluorene derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition com".

Company Profile
4.17.22
  • Jang; Sung Key - Gyeongsangbuk-do KR
  • Jang; Sung Key - Pohang-si KR
  • Jang; Sung Key - Seoul KR
  • Jang; Sung-Key - Pohang KR
  • Jang; Sung-Key - Gyungsangbuk-do KR
  • Jang; Sung-Key - Pohang-city KR
  • Jang; Sung Key - Kyungbuk KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fluorene derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition comprising same as effective ingredient for preventing or treating HCV-related disease
Grant 11,261,175 - Kim , et al. March 1, 2
2022-03-01
Aptamer against insulin receptor and pharmaceutical compostion containing the same
Grant 10,724,039 - Ryu , et al.
2020-07-28
Fluorene Derivative or Pharmaceutically Acceptable Salt Thereof, Preparation Method Therefor, and Pharmaceutical Composition Com
App 20200231573 - Kim; Byeong Moon ;   et al.
2020-07-23
Carbazole compound having anti-virus activity
Grant 10,421,779 - Keum , et al. Sept
2019-09-24
Aptamer Against Insulin Receptor And Pharmaceutical Composition Containing The Same
App 20190032060 - RYU; Sung Ho ;   et al.
2019-01-31
Carbazole Compound Having Anti-virus Activity
App 20180057527 - KEUM; Gyo Chang ;   et al.
2018-03-01
Benzidine derivative, method for preparing same, and pharmaceutical composition containing benzidine derivative for treating liver disease caused by hepatitis C virus
Grant 9,598,362 - Jang , et al. March 21, 2
2017-03-21
Oxazolidinone derivatives and composition for preventing or treating hepatitis C containing the same
Grant 9,422,274 - Jang , et al. August 23, 2
2016-08-23
Aptamer which selectively binds to ERBB2 receptor and uses thereof
Grant 9,309,515 - Lee , et al. April 12, 2
2016-04-12
Benzidine Derivative, Method For Preparing Same, And Pharmaceutical Composition Containing Benzidine Derivative For Treating Liver Disease Caused By Hepatitis C Virus
App 20160031810 - Jang; Sung Key ;   et al.
2016-02-04
Oxazolidinone derivatives and composition for preventing or treating Hepatitis C containing the same
App 20150148386 - JANG; Sung Key ;   et al.
2015-05-28
Method of diagnosing cancer using a nucleolin specific aptamer
Grant 9,018,185 - Lee , et al. April 28, 2
2015-04-28
Method of treating hyperproliferation of cells using a nucleolin specific aptamer
Grant 9,018,186 - Lee , et al. April 28, 2
2015-04-28
Aptamer Which Selectively Binds To Erbb2 Receptor And Uses Thereof
App 20150005368 - Lee; Jung Hwan ;   et al.
2015-01-01
Method of treating hyperproliferation of cells using a nucleolin specific aptamer
App 20140213636 - LEE; JUNG HWAN ;   et al.
2014-07-31
Aptamer sandwich assays
Grant 8,785,132 - Chae , et al. July 22, 2
2014-07-22
Method of diagnosing cancer using a nucleolin specific aptamer
App 20140093886 - LEE; JUNG HWAN ;   et al.
2014-04-03
Nucleolin specific aptamer and use thereof
Grant 8,569,252 - Lee , et al. October 29, 2
2013-10-29
Method Of Detecting A Target Using Aptamer-mediated Protein Precipitation Assay
App 20130059292 - KIM; Ki-Seok ;   et al.
2013-03-07
Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase D and raptor
Grant 8,278,263 - Ryu , et al. October 2, 2
2012-10-02
Aptamer Sandwich Assays
App 20110262922 - CHAE; Young-Chan ;   et al.
2011-10-27
Nucleolin Specific Aptamer and Use thereof
App 20100317723 - LEE; JUNG-HWAN ;   et al.
2010-12-16
Novel Use Of Grp 94 In Virus Infection
App 20100273144 - Jang; Sung-Key ;   et al.
2010-10-28
Efficiently Replicable Heptitis C Virus Mutant, A Heptitis C Virus Mutant Comprising Reporter Gene, A Method Of Preparing Of Hcv Vaccine Using The Same And A Method Of Screening Anti Hcv Composition Using The Same
App 20100215696 - Jang; Sung-Key ;   et al.
2010-08-26
Method of Regulating Mammalian Target-of-Rapamycin Activity by Interaction Between Phospholipase D and Raptor
App 20100184636 - Ryu; Sung-Ho ;   et al.
2010-07-22
Novel Use Of Grp 94 In Virus Infection
App 20090186039 - JANG; Sung-Key ;   et al.
2009-07-23
Methods Of Translation And/or Inflammation Blockade
App 20090023810 - JANG; Sung-Key ;   et al.
2009-01-22
Nanoporous membrane and method of fabricating the same
Grant 7,438,193 - Yang , et al. October 21, 2
2008-10-21
Nanoporous membrane and method of fabricating the same
App 20070080107 - Yang; Seung Yun ;   et al.
2007-04-12
System for functional analysis of polypeptides
App 20060246417 - Song; Ok-kyu ;   et al.
2006-11-02
Efficient hepatitis C virus replicon and its use in identifying antiviral compounds
Grant 6,689,559 - Wimmer , et al. February 10, 2
2004-02-10
Efficient hepatitis C virus replicon and its use in identifying antiviral compounds
App 20020098202 - Wimmer, Eckard ;   et al.
2002-07-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed